MedTrace Logo

Immunological Characteristics of COVID-19 Patients

NCT04679428 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 230

Last updated 2020-12-22

No results posted yet for this study

Summary

The study will look at the immunological characteristics of COVID-19 patients and determine neutralizing antibodies against SARS-CoV-2 virus.

Conditions

  • Covid19

Sponsors & Collaborators

  • National Institute of Chemistry, Slovenia

    collaborator UNKNOWN

  • The University Clinic of Pulmonary and Allergic Diseases Golnik

    lead OTHER

Principal Investigators

  • Peter Korošec, PhD · Head of the Laboratory for Clinical Immunology and Molecular Genetics

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-07
Primary Completion
2022-05-07
Completion
2023-05-07

Countries

  • Slovenia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04679428 on ClinicalTrials.gov